The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse

Clinical and Experimental Immunology

Volumn 115, Issue 2, 1999, Pages 260-267

  Ablamunits, V ^a   Elias, D ^a   Cohen, Irun R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Adoptive transfer therapy; Cytokines; Insulitis

Indexed keywords

CYCLOPHOSPHAMIDE; HEAT SHOCK PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE SEVERITY; FEMALE; HELPER CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MALE; MOUSE; NONHUMAN; PANCREAS ISLET DISEASE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CYCLOPHOSPHAMIDE; DIABETES MELLITUS, TYPE 1; FEMALE; HEAT-SHOCK PROTEINS; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; PEPTIDE FRAGMENTS; SEX CHARACTERISTICS; SPLEEN; T-LYMPHOCYTES;

EID: 0032940596     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00802.x     Document Type: Article

References (35)

1. 1 Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tocino Y. Breeding of a non-obese, diabetic strain of mice. Exp Anim 1980; 29:1-13.
2. 2 Bach J-F. Insulin-dependent diabetes mellitus as a β-cell targeted disease of immunoregulation. J Autoimmun 1995; 8:439-63.
3. 3 Baxter AJ, Adams MA, Mandel TE. Comparison of high- and low-diabetes-incidence NOD mouse strains. Diabetes 1989; 38:1296-300.
4. 4 Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis if IDDM. Therapeutic intervention by immunostimulation? Diabetes 1994; 43:613-21.
5. 5 Prochazka M, Gaskins HR, Shultz LD, Leiter EH. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 1992; 89:3290-4.
6. 6 Elias D, Cohen IR. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes 1995; 44:1132-8.
7. 7 Elias D, Meilin A, Ablamunits V, Birk OS, Carmi P, Konen-Waisman S, Cohen IR. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various β-cell antigens. Diabetes 1997; 46:758-64.
8. 8 Elias D, Reshev T, Birk OS, van der Zee R, Walker MD, Cohen IR. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci USA 1991; 88:3088-91.
9. 9 Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monako AP. An improved method for isolation of mouse pancreatic islets. Transplantation 1985; 40:437-8.
10. 10 Sedgwick JD, Holt PG. The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. J Immunol Methods 1986; 87:37-44.
11. 11 Harada M, Makino S. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 1984; 27:604-6.
12. 12 Yasunami R, Bach J-F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 1988; 18:481-4.
13. 13 Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14:619-33.
14. + T-lymphocytes. Diabetes 1988; 37:1108-12.
15. 15 Shehadeh NN, LaRosa F, Lafferty KJ. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 1993; 6:291-300.
16. 16 Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL. Suppression of insulitis in NOD mice by oral insulin administration is associated with selective expression of IL-4, IL-10, TGF-β and prostaglandin-E. Am J Pathol 1995; 147:1193-9.
17. + T cells. J Exp Med 1987; 166:823-32.
18. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 1988; 140:52-58.
19. 19 Peterson JD, Haskins K. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Diabetes 1996; 45:328-36.
20. 20 Pankewycz O, Strom TB, Rubin-Kelley VE. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes. Eur J Immunol 1991; 21: 873-9.
21. + Th1 and Th2 T cells derived from the spleens of diabetic NOD mice. J Clin Invest 1994; 95: 2979-85.
22. a donors. Diabetes 1993; 42:44-55.
23. 23 Serezze DV, Chapman HD, Varnum DS, Gerling I, Leiter EH, Shultz LD. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J Immunol 1997; 158:3978-86.
24. 24 Fitzpatric F, Lepault F, Homo-Delarche F, Bach J-F, Dardenne M. Influence of castration, alone or in combination with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology 1991; 129:1382-90.
25. 25 Fox HS. Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med 1992; 175:1409-12.
26. 26 Pukel C, Baqueriso H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 1988; 37:133-6.
27. 27 Debray-Sachs M, Carnaud C, Boitard C, Cohen H, Gresser I, Bedossa P, Bach J-F. Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ. J Autoimmun 1991; 4:237-48.
28. 28 Rabinovitch A, Suares-Pinzon WL, Sorensen O, Bleackley RC, Power RF. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 1995; 154:4874-82.
29. 29 Hultgren B, Huang X, Dybdal N, Stewart TA. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes 1996; 45:812-7.
30. 30 Boiturd C, Yasunami R, Dardenne M, Bach J-F. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 1989; 169:1669-80.
31. + cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 1996; 45:71-78.
32. 32 Jackson R, Rassi N, Crump T, Haynes B, Eisenbarth GS. The BB diabetic rat: profound T-cell lymphocytopenia. Diabetes 1981; 30: 887-9.
33. 33 Rossini AA, Faustman D, Woda BA, Like AA, Szymanski I, Mordes JP. Lymphocyte transfusions prevent diabetes in the Bio-Breding/Worcester rat. J Clin Invest 1984; 74:39-46.
34. + T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats. J Exp Med 1987; 166:461-75.
35. 35 Cohen IR. Treatment of autoimmune disease: to activate or to deactivate? Chem Immunol 1995; 60:150-60.